Back to top
more

OrthoPediatrics (KIDS)

(Delayed Data from NSDQ)

$30.26 USD

30.26
100,943

+0.32 (1.07%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $30.25 -0.01 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for KIDS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for OrthoPediatrics Corp falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 82 120 55 85 72
Receivables 35 25 18 17 16
Notes Receivable 0 0 0 0 1
Inventories 106 78 58 53 38
Other Current Assets 4 4 3 3 1
Total Current Assets 227 227 134 158 128
Net Property & Equipment 41 34 29 27 21
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 168 167 142 135 45
Deposits & Other Assets 3 0 0 0 0
Total Assets 439 428 304 320 195
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 13 11 9 10 6
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 11 7 5 11 4
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 18 13 15 14 3
Total Current Liabilities 42 31 30 35 14
Mortgages 0 0 0 0 0
Deferred Taxes/Income 5 6 5 6 12
Convertible Debt 0 0 0 0 0
Long-Term Debt 10 1 1 1 26
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 5 11 44 44 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 62 49 79 86 52
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 580 561 395 389 271
Retained Earnings -198 -177 -178 -162 -129
Other Equity -6 -5 8 8 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 377 379 225 235 142
Total Liabilities & Shareholder's Equity 439 428 304 320 195
Total Common Equity 377 379 225 235 142
Shares Outstanding 23.30 22.80 19.60 19.50 16.70
Book Value Per Share 16.18 16.61 11.50 12.04 8.52

Fiscal Year End for OrthoPediatrics Corp falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 82 84 95 109
Receivables NA 35 38 34 27
Notes Receivable NA 0 0 0 0
Inventories NA 106 101 91 85
Other Current Assets NA 4 4 4 4
Total Current Assets NA 227 226 223 225
Net Property & Equipment NA 41 40 40 37
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 168 165 171 164
Deposits & Other Assets NA 3 1 1 0
Total Assets NA 439 432 435 426
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 13 23 21 17
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 11 9 8 6
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 18 17 15 12
Total Current Liabilities NA 42 48 44 35
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 5 5 6 6
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 10 1 1 1
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 4 4 11
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 62 58 55 53
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 580 578 575 563
Retained Earnings NA -198 -191 -186 -184
Other Equity NA -6 -12 -8 -6
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 377 374 380 373
Total Liabilities & Shareholder's Equity NA 439 432 435 426
Total Common Equity 0 377 374 380 373
Shares Outstanding 23.50 23.30 23.30 23.30 23.20
Book Value Per Share 0.00 16.18 16.07 16.32 16.08